Search results
Results from the WOW.Com Content Network
The Electronic Vaccination Data System (EVDS) is a digital platform developed by the National Department of Health of the South African government to manage the country's COVID-19 vaccination program. Enrolment is currently available for everyone over the age of 12 [3] and the platform can also generate a digital vaccine certificate. [4]
The US delivers Pfizer COVID-19 vaccines to South Africa as part of the COVAX initiative in 2021. South Africa has so far paid R283 million ($20 million) to the organization in December 2020. COVAX has delivered 1.4 million doses of the Pfizer–BioNTech vaccine to the country on 28 June 2021. [67] [68]
South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. [16] Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. [17]
Digital Vaccine Card Used in South Africa (Version 2) Current South African COVID-19 Vaccination Record Cards Contain Identification information and provision for 3 doses of vaccines. [38] The eVaccine Card or Digital Vaccine Certificates can be assessed at https://vaccine.certificate.health.gov.za/ Archived 2021-10-17 at the Wayback Machine
Moderna Inc. has completed the submission process for requesting full authorization for its coronavirus vaccine for individuals 18 and over, the company announced Wednesday.
On 6 February 2021, SAHPRA approved the Oxford–AstraZeneca COVID-19 vaccine. [6] After a clinical trial proved to not be effective for mild to moderate illness caused by the 501.V2 variant. The vaccination program was announced to be put on a hold. [7]
[144] [145] [146] In April 2021, South Africa suspended its rollout of the vaccine. [147] The program resumed in April 2021. In February 2021, Bahrain authorized the vaccine for emergency use. [148] [149] In February 2021, the South Korean Ministry of Food and Drug Safety began a review of Johnson & Johnson's application for approval of its ...
South Korea granted approval of the AstraZeneca vaccine on 10 February 2021, thus becoming the first vaccine to be approved for use in that country. The regulator recommended the two-shot regimen be used in all adults, including the elderly, noting that consideration is needed when administering the vaccine to individuals over 65 years of age ...